Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-605 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as chemobrain. A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship care...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 30, 2018 Category: Research Source Type: funding
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)
Funding Opportunity PAR-18-606 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as chemobrain. A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship care...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 30, 2018 Category: Research Source Type: funding
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21)
Funding Opportunity Number: PAR-16-213 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationHealthCFDA Number: 93.395Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with...
Source: Grants.gov - April 22, 2016 Category: Research Tags: Education Health Source Type: funding
Leveraging Cognitive Neuroscience Research to Improve Assessment of Cancer Treatment Related Cognitive Impairment (R01)
Funding Opportunity Number: PAR-16-212 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationHealthCFDA Number: 93.395Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with...
Source: Grants.gov - April 22, 2016 Category: Research Tags: Education Health Source Type: funding
Leveraging Cognitive Neuroscience Research to Improve Assessment of Cancer Treatment Related Cognitive Impairment (R01)
Funding Opportunity PAR-16-212 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as chemobrain. A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship c...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 21, 2016 Category: Research Source Type: funding
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21)
Funding Opportunity PAR-16-213 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as chemobrain. A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship c...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 21, 2016 Category: Research Source Type: funding
Trudy Bush Fellowships for Cardiovascular Disease Research in Women's Health
Trudy Bush Fellowships for Cardiovascular Disease Research in Women's Health Applicants must submit abstracts to the EPI/Lifestyle 2015 Scientific Sessions, scheduled for March 3 -6, 2015 in Baltimore, Maryland. The Abstract and Award Application Deadline is Wednesday, October 15, 2014 at 11:59 PM CDT. The Trudy Bush Fellowship for Cardiovascular Disease Research in Women’s Health is named for Trudy Bush, Ph.D., M.H.S., to honor her outstanding leadership in the field of women’s health and contributions to cardiovascular science. The winners of the Trudy Bush Fellowships will be announced du...
Source: ScanGrants feed - July 2, 2014 Category: Research Authors: Council on Epidemiology and Prevention Source Type: funding
Request for Proposals: Enabling Effective Conversations Regarding Menopausal Vasomotor Symptoms and Other Conditions Associated with Menopause Utilizing Electronic Health Records
Letter of Intent due date: June 24, 2014 The RFP model is a two-stage process. Stage 1 is the submission of the LOI. After review of the LOI, you may be invited to submit your Full Grant Proposal. Stage 2 is the submission of the Full Grant Proposal. Specific Area of Interest for this RFP: Design and implement a learning and change-based program which enables effective dialogue between health care providers (HCPs) and women regarding the diagnosis and management of menopausal vasomotor symptoms (VMS) and other conditions associated with menopause. The program should incorporate current treatment algorithms...
Source: ScanGrants feed - June 2, 2014 Category: Research Authors: Pfizer Source Type: funding
